HoloMoA

Holographic identification of mechanism of action of a drug

Unstaining, rapid, and reliable technology

Technology:
  • Antimicrobial compound/strategy
  • Infection prevention
  • Antimicrobial stewardship
  • Microbial diagnostics
  • Removal antibiotics/bacteria

Microorganisms:
  • Bacteria
  • Fungi
  • Yeasts
  • Viruses
  • Parasites

Application:
  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Research
  • Development
  • Validation
  • Market entry
  • Marketed product

Organization:
  • Company
  • Academia
  • Institute
  • NGO
  • Government

Partnering:
  • License
  • Co-develop
  • Outsource
  • Joint Venture
  • Sell

Funding organisation:
  • OTHER / NA
  • CARB-X
  • FIND
  • GARDP
  • REPAIR

Infectious disease area:
  • UTI
  • STI
  • BSI
  • RTI
  • GII
  • SSTI
  • CNSI
  • IAI
  • SSI

Geographic origin:
  • Eurasia
  • North America
  • South America
  • Africa
  • Oceania


Non for profit organization in the field of microbiology and infectious disease.
We do research in 4 fields: antimicrobials, vaccine, diagnostics, microbiota.
We have numerous technologies available: microscopy, microfluidics (organ on chip), microbiology wet lab, OMIC wet lab and data analysis, biostatistics, machine learning, data management, software development.

In silico design of antimicrobial peptides. This is a new technology aiming at tailor and/or optimize peptide for their antimicrobial capabilities, as well as other important characteristics (eg reduced toxicity).


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed